Maritoclax

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Maritoclax

CAS No. : 1227962-62-0

MCE 国际站：Maritoclax

产品活性：Maritoclax (Marinopyrrole A) 是一种新颖的 Mcl-1 特异性抑制剂，IC₅₀ 值为 10.1 μM，对 BCL-xl 的 IC₅₀ 值 > 80 μM。

研究领域：Apoptosis

作用靶点：Bcl-2 Family

In Vitro: Maritoclax (Marinopyrrole A) blocks the binding of Bim BH3 α-helix to Mcl-1 but not Bcl-XL. Maritoclax (Marinopyrrole A) markedly inhibits the viability of Mcl-1-IRES-BimEL cells (EC₅₀=1.6 μM) with a selectivity greater than 40-fold over Bcl-2-IRES-BimEL (EC₅₀=65.1 μM) and Bcl-XL-IRES-BimEL (EC₅₀=70.0 μM) cells. Maritoclax (Marinopyrrole A) induces cell death selectively in Mcl-1-dependent but not Bcl-2- or Bcl-XL-dependent leukemia cells. Maritoclax (Marinopyrrole A) induces proteasome-mediated Mcl-1 degradation without induction of Mcl-1 phosphorylation and Noxa expression. Maritoclax (Marinopyrrole A) inhibits Mcl-1 interaction with Bim in intact cells and triggers cytochrome c release from isolated mitochondria. Maritoclax (Marinopyrrole A) synergistically sensitizes lymphoma/leukemia cells to ABT-737. Maritoclax (Marinopyrrole A) shows activity against all tested S. aureus strains, including glycopeptide-intermediate and vancomycin-resistant MRSA, and has potent activities against other Gram-positive organisms. In addition, Maritoclax (Marinopyrrole A) is active against H. influenzae but is inactive against other tested Gram-negative strains. Maritoclax (Marinopyrrole A) displays substantial concentration-dependent killing against MRSA strain TCH1516 and is far more rapid in its antibiotic action than either vancomycin or linezolid. Maritoclax exhibits a favorable therapeutic index, with 50% inhibitory concentrations (IC₅₀) in excess of 20× above the MIC in each case: 32 to 64 μg/mL against HeLa cells and 8 to 32 μg/mL against L929 cells. Maritoclax (Marinopyrrole A) (3 μM) induced-cell death is associated with MCL1 decrease and translation inhibition. Maritoclax (Marinopyrrole A) induces a dephosphorylation of EIF4EBP1 concomitant to a decrease of EIF4E phosphorylation. Maritoclax (Marinopyrrole A) is much more effective against Bcl-2-dependent RS4;11 cells (IC₅₀: 2 μM) when compared to Mcl-1-dependent HeLa cells (IC₅₀: 20 μM).

相关产品：Covalent Screening Library Plus  |  Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Anti-Cancer Compound Library  |  Covalent Screening Library  |  Anti-Blood Cancer Compound Library  |  Mitochondria-Targeted Compound Library  |  Human Metabolite Library  |  Highly Selective Inhibitors Library  |  Venetoclax  |  Navitoclax  |  Polyinosinic-polycytidylic acid  |  S63845  |  ABT-737  |  A-1331852  |  AZD-5991  |  BT2  |  Chlorin e6  |  A-1155463  |  MIK665  |  Estradiol benzoate  |  BAI1  |  Benzbromarone  |  Obatoclax Mesylate  |  Digitoxin  |  Chelerythrine chloride  |  BI-3802  |  AZD4320  |  Dehydrocorydaline  |  WEHI-539 hydrochloride  |  Tapotoclax  |  Amantadine  |  A-1210477  |  Gambogic Acid  |  BTSA1  |  Bax inhibitor peptide V5  |  UMI-77  |  Cardamonin  |  TCPOBOP

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds